MedPath

Fortuderm Ltd.

Ownership
Private
Employees
-
Market Cap
-
Website

Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept Study

Phase 1
Conditions
Psoriasis Vulgaris
Interventions
First Posted Date
2012-10-08
Last Posted Date
2012-10-08
Lead Sponsor
Fortuderm Ltd.
Target Recruit Count
30
Registration Number
NCT01702324
Locations
🇮🇱

Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

© Copyright 2025. All Rights Reserved by MedPath